A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study
- PMID: 15939059
- DOI: 10.1016/j.atherosclerosis.2004.12.026
A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study
Abstract
We have compared the predictive value of the PROCAM and Framingham risk algorithms in healthy UK men from the Second Northwick Park Heart Study (NPHS-II) (50-64 years at entry), followed for a median of 10.8 years for coronary heart disease (CHD) events. For PROCAM, the area under the receiver operating characteristic (ROC) curve was 0.63 (95% CI, 0.59-0.67), and not significantly different (p = 0.46) from the Framingham score, 0.62 (0.58-0.66). Sensitivities for a 5% false-positive rate (DR(5)) were 13.8 and 12.4%, respectively. Calibration analysis for PROCAM gave a ratio of observed to expected events of 0.46 (Hosmer-Lemeshow test, p < 0.0001) and 0.47 for Framingham (p < 0.0001). Using measures taken at 5 years of high-density lipoprotein cholesterol and (estimated) low-density lipoprotein cholesterol levels increased the ROC by only 1%. An NPHS-II risk algorithm, developed using a 50% random subset, and including age, triglyceride, total cholesterol, smoking status, and systolic blood pressure at recruitment, gave an ROC of 0.64 (0.58-0.70) with a DR(5) of 10.7% when applied to the second half of the data. Adding family history and diabetes increased the DR(5) to 18.4% (p = 0.28). Adding lipoprotein(a) >26.3 mg/dL (relative risk 1.6, 1.1-2.4) gave a DR(5) of 15.5% (p = 0.55), while adding fibrinogen levels (relative risk for 1S.D. increase = 1.5, 1.1-2.0) had essentially no additional impact (DR(5) = 16.9%, p = 0.95). Thus, the PROCAM algorithm is marginally better as a risk predictor in UK men than the Framingham score, but both significantly overestimate risk in UK men. The algorithm based on NPHS-II data performs similarly to those for PROCAM and Framingham with respect to discrimination, but gave an improved ratio of observed to expected events of 0.80 (p = 0.01), although no score had a high sensitivity. Any novel factors added to these algorithms will need to have a major impact on risk to increase sensitivity above that given by classical risk factors.
Similar articles
-
Effect of serum lipid level change on 10-year coronary heart risk distribution estimated by means of seven different coronary risk scores during one-year treatment.Med Pregl. 2014 Jul-Aug;67(7-8):208-15. Med Pregl. 2014. PMID: 25151760
-
Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation.Int J Epidemiol. 2005 Apr;34(2):413-21. doi: 10.1093/ije/dyh405. Epub 2005 Jan 19. Int J Epidemiol. 2005. PMID: 15659467
-
Predicting coronary heart disease risk using the Framingham and PROCAM equations in dyslipidaemic patients without overt vascular disease.Int J Clin Pract. 2007 Oct;61(10):1643-53. doi: 10.1111/j.1742-1241.2007.01527.x. Int J Clin Pract. 2007. PMID: 17877651
-
Predicting the risk of coronary heart disease I. The use of conventional risk markers.Atherosclerosis. 2010 Dec;213(2):345-51. doi: 10.1016/j.atherosclerosis.2010.06.019. Epub 2010 Jun 16. Atherosclerosis. 2010. PMID: 20637467 Review.
-
HDL-cholesterol and cardiac disease: which table to use?Ann Clin Biochem. 2002 Jan;39(Pt 1):12-21. doi: 10.1258/0004563021901667. Ann Clin Biochem. 2002. PMID: 11853184 Review.
Cited by
-
Evaluating the impact of automatic positive airway pressure therapy on cardiovascular risk index and vascular behavior in patients with obstructive sleep apnea: a study on heterogeneity in the therapeutic response.J Clin Sleep Med. 2024 Sep 1;20(9):1435-1444. doi: 10.5664/jcsm.11162. J Clin Sleep Med. 2024. PMID: 38648118
-
Inclisiran-A Revolutionary Addition to a Cholesterol-Lowering Therapy.Int J Mol Sci. 2023 Apr 6;24(7):6858. doi: 10.3390/ijms24076858. Int J Mol Sci. 2023. PMID: 37047830 Free PMC article. Review.
-
Clinical Utility of a Coronary Heart Disease Risk Prediction Gene Score in UK Healthy Middle Aged Men and in the Pakistani Population.PLoS One. 2015 Jul 2;10(7):e0130754. doi: 10.1371/journal.pone.0130754. eCollection 2015. PLoS One. 2015. PMID: 26133560 Free PMC article.
-
Effect of SORT1, APOB and APOE polymorphisms on LDL-C and coronary heart disease in Pakistani subjects and their comparison with Northwick Park Heart Study II.Lipids Health Dis. 2016 Apr 26;15:83. doi: 10.1186/s12944-016-0253-0. Lipids Health Dis. 2016. PMID: 27112212 Free PMC article.
-
Genetic testing for atherosclerosis risk: inevitability or pipe dream?Can J Cardiol. 2008 Nov;24(11):851-4. doi: 10.1016/s0828-282x(08)70194-6. Can J Cardiol. 2008. PMID: 18987759 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources